Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types

Muntasir M. Majumder, Aino-Maija Leppä, Monica Hellesøy, Paul Dowling, Alina Malyutina, Reidun Kopperud, Despina Bazou, Emma Andersson, Alun Parsons, Jing Tang, Olli Kallioniemi, Satu Mustjoki, Peter O´Gorman, Krister Wennerberg, Kimmo Porkka, Bjørn T. Gjertsen, Caroline A. Heckman

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalHaematologica
Volume105
Issue number6
Pages (from-to)1527-1538
Number of pages12
ISSN0390-6078
DOIs
Publication statusPublished - Jun 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3122 Cancers
  • ACUTE MYELOID-LEUKEMIA
  • GLUCOCORTICOID-INDUCED APOPTOSIS
  • CHRONIC LYMPHOCYTIC-LEUKEMIA
  • MASS CYTOMETRY
  • MIDOSTAURIN
  • INHIBITORS
  • S100A8
  • 1ST-IN-HUMAN
  • SENSITIVITY
  • VENETOCLAX
  • 3111 Biomedicine
  • ACUTE MYELOID-LEUKEMIA
  • GLUCOCORTICOID-INDUCED APOPTOSIS
  • CHRONIC LYMPHOCYTIC-LEUKEMIA
  • MASS CYTOMETRY
  • MIDOSTAURIN
  • INHIBITORS
  • S100A8
  • 1ST-IN-HUMAN
  • SENSITIVITY
  • VENETOCLAX

Cite this